What Is Peripheral Neuropathy?
Peripheral neuropathy is the general term for injury to the nerves of the peripheral nervous system — the system formed by all nervous structures that lie outside the brain and spinal cord. These nerves transmit motor commands to the muscles, conduct sensation from the skin and viscera to the central nervous system, and regulate autonomic functions such as sweating, heart rate, and intestinal motility.
When these nerves are damaged, the clinical picture depends on which fibers are affected: small sensory fibers produce burning pain, tingling, and loss of thermal sensation; large sensory fibers cause numbness, loss of proprioception, and imbalance; motor fibers cause weakness and atrophy; autonomic fibers produce postural hypotension, sweating changes, and gastrointestinal dysfunction.
Peripheral neuropathy is not a single disease, but rather a final common syndrome of more than 100 distinct conditions, ranging from metabolic diseases (notably diabetes) to toxic causes (chemotherapy, alcohol), inflammatory (Guillain-Barré syndrome, chronic inflammatory polyneuropathy), genetic (Charcot-Marie-Tooth), and mechanical compression (carpal tunnel syndrome, meralgia paresthetica).
More than 100 causes
Diabetes is the most common cause worldwide, but alcohol, chemotherapy, B12 deficiency, hypothyroidism, and autoimmune diseases represent potentially reversible diagnoses.
Early diagnosis changes prognosis
Metabolic and nutritional causes can be reversed if treated early. Delayed investigation turns treatable neuropathy into permanent sequelae.
Neuropathic pain is different
It responds poorly to common analgesics (acetaminophen, NSAIDs) and requires specific medications (gabapentinoids, dual antidepressants) and neuromodulatory approaches such as acupuncture.
Epidemiology
Overall prevalence of peripheral neuropathy in the adult population is estimated at 2.4%, rising to 8% in people over 55 years of age. Considering only patients with diabetes mellitus, the cumulative prevalence of distal symmetric polyneuropathy reaches 50% over 25 years of disease, and up to 25% of diabetics already have some degree of neuropathy at diagnosis.
In cancer patients receiving neurotoxic chemotherapy (platinum compounds, taxanes, vinca alkaloids, bortezomib), the incidence of chemotherapy-induced neuropathy reaches 30 to 70% depending on the regimen, cumulative dose, and individual factors — being one of the main causes of dose reduction or early discontinuation of cancer treatment.
About 20 to 30% of peripheral neuropathies remain idiopathic after complete investigation, although recent studies show that a significant portion of these cases corresponds to small-fiber neuropathies with etiology in prediabetes, mild autoimmune diseases, or genetic variants not yet fully characterized.
Causes and Classification
Classifying neuropathy is the first step in diagnostic reasoning. The most useful classifications in practice combine the distribution pattern, the speed of onset, and the type of fiber affected.
Distal symmetric polyneuropathy
Stocking-and-glove pattern. Causes: diabetes, alcohol, B12 deficiency, hypothyroidism, chemotherapy, uremia. The most common form in clinical practice.
Mononeuropathy
Involvement of a single nerve. Generally compressive: carpal tunnel (median), meralgia paresthetica (lateral femoral cutaneous), ulnar neuropathy at the elbow, common peroneal at the knee.
Mononeuritis multiplex
Sequential and asymmetric involvement of individual nerves. Suggests vasculitis (polyarteritis nodosa, ANCA), leprosy, or diabetes.
Polyradiculoneuropathy
Guillain-Barré syndrome (acute) and CIDP (chronic). Proximal involvement and significant weakness. Neurologic emergency in its acute form.
Pathophysiology
Injury mechanisms vary by etiology but converge on three major final pathways: axonal damage (Wallerian or "dying-back" degeneration), demyelination (loss of the myelin sheath by Schwann cells), and microvascular injury of the vessels that nourish the nerves (vasa nervorum).
In diabetic neuropathy, hyperglycemia activates the polyol pathway, generates advanced glycation end products (AGEs), increases mitochondrial oxidative stress, and reduces endoneural blood flow. In chemotherapy-induced neuropathy, taxanes destabilize microtubules, and platinum compounds form adducts on neuronal DNA in the dorsal root ganglion. In vasculitis, ischemic occlusion blocks the vessels supplying the nerves.
Regardless of the trigger, peripheral and central sensitization perpetuates pain even after the injurious stimulus ceases: TRP receptors, Nav1.7 and Nav1.8 sodium channels, and hyperactivated spinal glia pathologically amplify the nociceptive signal, creating persistent neuropathic pain. This final cascade is what justifies channel-modulating drugs and neuromodulatory therapies such as medical acupuncture.
Symptoms
Symptoms reflect the fiber type involved. Recognizing the pattern is essential for diagnosis:
Positive sensory symptoms
Burning, electric shocks, pinpricks, tingling, lancinating pain, allodynia (pain on light touch), hyperalgesia (exaggerated response to a painful stimulus).
Negative sensory symptoms
Numbness, loss of thermal and pain sensation, loss of proprioception (gait instability, especially in the dark), risk of silent ulcer and burn.
Motor symptoms
Distal weakness (difficulty climbing stairs, tripping, dropping objects), muscle atrophy, fasciculations, frequent cramps.
Autonomic symptoms
Postural hypotension, resting tachycardia, gastroparesis, alternating diarrhea-constipation, erectile dysfunction, altered sweating, heat intolerance.
Diagnosis
Diagnosis combines detailed history-taking, structured neurologic examination, an oriented laboratory panel, and, when indicated, nerve conduction study and electromyography and nerve or skin biopsy.
The neurologic exam assesses segmental strength, deep reflexes (frequently abolished at the Achilles), tactile sensation (10 g monofilament on the diabetic patient's feet), vibration sense (128 Hz tuning fork), proprioception, and gait. A positive Romberg sign suggests large-fiber involvement.
Nerve conduction study and electromyography differentiate axonal and demyelinating patterns, define whether there is isolated or combined sensory and motor involvement, and help localize compressive mononeuropathies. In suspected small-fiber neuropathy (normal neurologic examination and EMG with distal sensory symptoms), skin biopsy with intraepidermal nerve fiber count is the gold standard.
Treatment
Treatment has two axes: treat the cause (glycemic control in diabetes, B12 supplementation, withdrawal of the toxic agent, immunotherapy in autoimmune causes) and control neuropathic pain. The main pharmacologic classes with solid evidence in international guidelines (NeuPSIG, Cochrane) are:
Gabapentinoids
Gabapentin and pregabalin. Block the α2δ subunit of calcium channels. First-line. Start low, titrate to tolerance.
Dual antidepressants
Duloxetine and venlafaxine. Modulate descending serotonergic and noradrenergic pathways. Good option in patients with co-occurring depression.
Tricyclics
Amitriptyline and nortriptyline at analgesic doses (10-50 mg). Robust efficacy. Caution with anticholinergic effects in older adults.
Topical and physical measures
Capsaicin 8% and lidocaine 5% patches for localized areas. Strict diabetic foot care. Rehabilitation for proprioceptive retraining and fall prevention.
Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Acupuncture for the treatment of diabetic peripheral neuropathy in the elderly: a systematic review and meta-analysis
“The meta-analysis showed that acupuncture is an effective option for older adults with diabetic neuropathy: it reduces pain and numbness in the feet and legs, improves nerve function as assessed by conduction velocity, and aids glycemic control compared with conventional medications alone.”
ACUDIN: ACUpuncture and laser acupuncture for treatment of DIabetic peripheral Neuropathy — randomized, placebo-controlled trial
“Randomized placebo-controlled trial evaluating whether traditional or laser acupuncture improves nerve function in patients with diabetic neuropathy. It assessed objective outcomes via nerve conduction alongside patient-reported symptoms.”
Acupuncture as Treatment
Medical acupuncture has a recognized role as a complementary therapy for peripheral neuropathy, especially in painful forms. Randomized clinical trials — including meta-analyses in Pain Medicine and the Cochrane — show an average reduction of 30 to 50% in pain intensity, improvement in sleep quality, and reduction in the need for analgesics in patients with diabetic neuropathy and chemotherapy-induced neuropathy.
Described mechanisms include stimulating neurotrophin release (NGF, NT-3) to support peripheral axonal regeneration, activating the descending serotonergic and noradrenergic pain-inhibition system, modulating TRPV1 and TRPA1 channels in nociceptors, reducing spinal sensitization, and improving endoneural microcirculation through local release of nitric oxide and CGRP.
Electroacupuncture at low frequencies (2 Hz) is particularly useful in painful neuropathy, since it reproduces stimulation patterns involved in β-endorphin release and modulation of spinal synaptic plasticity. The average number of sessions varies between 10 and 15, with monthly maintenance in chronic cases.
Myths and Facts
Myth vs. Fact
Neuropathy is always incurable.
Neuropathies from vitamin deficiency, hypothyroidism, celiac disease, and some autoimmune causes can fully reverse once the underlying cause is treated.
If blood glucose is controlled, diabetic neuropathy will not progress.
Even with optimal control, neuropathy can progress in some patients — disease duration, prior mean glycemia (metabolic memory), and genetic factors influence prognosis.
NSAIDs and acetaminophen resolve neuropathic pain.
Neuropathic pain responds poorly to common analgesics. Treatment requires specific modulating drugs (gabapentinoids, dual antidepressants, tricyclics) and neuromodulatory approaches.
When to Seek Help
Seek a physician (general practitioner, endocrinologist, neurologist, or pain physician) whenever you have persistent tingling, numbness, or burning in the feet or hands, especially if you have diabetes, chronic alcohol use, are on chemotherapy, or are over 50 years old. Diagnostic delay turns treatable neuropathy into sequelae.
Frequently Asked Questions
No. Acupuncture is a complementary therapy that reduces neuropathic pain, improves sleep and quality of life, and may support peripheral nerve regeneration in experimental studies. It does not replace treatment of the underlying cause (glycemic control, vitamin replacement, withdrawal of the toxic agent) or first-line drug therapy when indicated.
On average 10 to 15 sessions for a significant clinical response, typically one to two times per week. Chronic cases usually continue monthly sessions to sustain results.
No, when performed by a trained acupuncture physician. Stimulation intensity is adjusted to each patient's sensitivity. Main contraindications: pacemaker carriers (electroacupuncture near the chest) and neuropathy with damaged skin or active ulcers at the insertion site.
Yes. Acupuncture is considered safe during chemotherapy, with evidence of reduced chemotherapy-induced neuropathy, nausea, and cancer-related fatigue. In patients with significant thrombocytopenia (< 50,000) or active febrile neutropenia, the indication should be individualized with the oncologist.
Polyneuropathy is a form of peripheral neuropathy in which multiple nerves are affected simultaneously, in a symmetric, distal pattern. Mononeuropathy (a single nerve, generally compressive) and mononeuritis multiplex (several nerves, asymmetric pattern) are other forms of peripheral neuropathy with distinct causes and treatments.
Related Reading
Deepen your knowledge with related articles
Diabetic Neuropathy
The most common metabolic cause of peripheral neuropathy.
Chemotherapy-Induced Neuropathy
CIPN — pathophysiology, prevention, and the role of acupuncture.
Carpal Tunnel Syndrome
The most frequent compressive mononeuropathy.
Mechanisms of Acupuncture
How acupuncture acts on nociceptive pathways and neurotrophins.